A nationwide Japanese cohort of 224 patients found a 7.3 percent 3-year local recurrence rate after transanal total ...

Diagnostic and surgical approaches to treating the disease are evolving — just as rates are spiking. Learn how the surgical ...

A newly approved immunotherapy was effective for some forms of rectal cancer without the need for additional treatments.

Patients treated for rectal cancer at hospitals that are accredited by the American College of Surgeons (ACS) National Accreditation Program for Rectal Cancer (NAPRC) were less likely to have cancer ...

Some people with rectal cancer may now be able to skip chemotherapy, radiation and surgery. The U.S. Food and Drug Administration (FDA) on Monday approved the immunotherapy (Jemperli) for certain ...

Neoadjuvant radiotherapy followed by surgery can improve overall survival compared with surgery alone in certain patients with locally advanced rectal cancers, most notably in those with lower rectal ...

Transgene and University of Copenhagen are collaborating on the investigator-sponsored OV-PRIME-R trial evaluating armed oncolytic virus BT-001 ...

BT-001, an armed oncolytic virus, enters Phase 1 clinical trial targeting pMMR rectal cancer — the 95% of patients who have ...

I had part of my large intestine removed along with the tumor during my colorectal cancer surgery. The actual tumor When I ...

An individual participant data meta-analysis (IPDMA) found that patients who underwent laparoscopic liver resection (LLR) to ...

Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world ...

A cross-sectional study of 105 Iranian colorectal cancer patients found that 54.3% had moderate-to-severe malnutrition and 40 ...